Cervical Recuperation After Vaginal Delivery

Overview

Patients after vaginal delivery will undergo 3 trans-vaginal ultrasounds in order to examine the process of cervical recuperation post delivery.

Full Title of Study: “Sonography Evaluation of Cervical Recuperation After Vaginal Delivery”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 29, 2020

Detailed Description

Patients after vaginal delivery will be recruited after receiving a full explanation and signing an informed consent. The goal of the study is to examine cervical length after vaginal delivery at 3 different time intervals: 1. 8 hours post delivery. 2. 24 hours post delivery. 3. 48 hours post delivery. At each interval a trans-vaginal ultrasound will be performed, evaluating cervical length. At the end of the 3rd and final ultrasound, the patient will finish her participation in the study/ Information regarding obstetric conditions such as labor induction, gestational age at the time of delivery etc. will be collected from patients' electronic files.

Interventions

  • Device: Trans-vaginal ultrasound
    • Three trans-vaginal ultrasounds, the 1st to be performed 8 hours post delivery, the 2nd 24 hours after delivery and the 3rd 48 hours after delivery.

Arms, Groups and Cohorts

  • Patients after vaginal delivery
    • Patients after vaginal delivery willing to undergo 3 trans-vaginal ultrasounds within the 48 hours after delivery.

Clinical Trial Outcome Measures

Primary Measures

  • Cervical length after vaginal delivery.
    • Time Frame: Up to 48 hours post delivery.
    • Measurement of cervical length 8, 24, 48 hours after vaginal delivery by trans-vaginal ultrasound.

Secondary Measures

  • Differences in cervical length after vaginal delivery.
    • Time Frame: Up to 48 hours post delivery.
    • Differences in cervical length after vaginal delivery as a factor of gestational age at delivery, means of labor induction, parity, etc.

Participating in This Clinical Trial

Inclusion Criteria

  • Any patient after vaginal delivery. Exclusion Criteria:

  • Any patient after cesarean section.

Gender Eligibility: Female

Female patients only.

Minimum Age: 18 Years

Maximum Age: 44 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Rambam Health Care Campus
  • Provider of Information About this Clinical Study
    • Principal Investigator: ROY LAUTERBACH MD, Principal investigator – Rambam Health Care Campus
  • Overall Official(s)
    • Roy Lauterbach, MD, Principal Investigator, Rambam Health Care Campus

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.